Breast Care A-Z · Condition · PAPILLOMA

Intraductal papilloma

also: breast papilloma, duct papilloma, solitary intraductal papilloma · pronounced in-tra-DUCT-al pap-ih-LOH-ma

An intraductal papilloma is a small, benign wart-like growth inside a breast duct, and a common cause of blood-stained or clear discharge from a single duct. You may have been told you have one, or be reading about nipple discharge — the word "papilloma" sounds more concerning than it usually is.

Quick answers

Is an intraductal papilloma cancer?

No. An intraductal papilloma is benign by definition. A small minority show atypical features on examination of the whole specimen, and very occasionally a papilloma is associated with DCIS in the same area — which is one reason surgical removal is usually recommended even after a benign needle biopsy result.

Will the discharge stop on its own?

Sometimes the discharge from a small papilloma settles spontaneously, but it often persists or recurs. Surgical removal usually stops it reliably. There is no clinical pressure to remove an asymptomatic, biopsy-confirmed papilloma immediately, but ongoing discharge is the usual reason patients choose to proceed.

Can I still breastfeed if I have a papilloma?

Usually yes. Removing a single duct (microdochectomy) leaves the other ducts intact, and most patients who have breastfed after the operation report normal milk supply from the operated breast. Multiple-duct surgery affects breastfeeding more significantly and would be discussed at consultation if relevant.

Intraductal Papilloma -- Breastory Encyclopaedia Plate LXII Plate covering intraductal papilloma: central vs peripheral, investigation, differential of nipple discharge, and management pathway. ONCOLOGY - BENIGN BREAST CONDITIONS PLATE LXII intraductal papilloma central papilloma - peripheral papilloma - papillary lesion B3 a benign epithelial tumour within a breast duct, classically presenting with spontaneous bloody or serous nipple discharge FIG 01 -- Duct cross-section with intraluminal papilloma (left) | Nipple discharge diagram (right) duct wall (myoepithelial) lactiferous sinus bloody discharge papilloma single duct involvement (central) i -- fibrovascular stalk (papilloma attachment point) ii -- arborescent papillary frond (branching structure) iii -- epithelial covering (luminal + myoepithelial cells) iv -- intraluminal blood / discharge v -- single duct involved (central) vs multiple (peripheral) Central vs Peripheral papilloma Central: single large subareolar duct Age: 30-50, bloody discharge Risk: benign, low malignant risk Peripheral: multiple TDLU-based, bilateral Association: ADH / DCIS, higher risk Peripheral risk: >20% if atypical Investigation MRI (if needed) identifies the discharging duct USS (subareolar lesion) confirms papilloma location Microdochectomy single duct excision (Hadfield's op) FIG 02 -- Central vs Peripheral papilloma: comparison Feature Central papilloma Peripheral papilloma Location Subareolar large duct Peripheral TDLU Number Single Multiple Age 30-50 Any age Discharge Bloody / serous, spontaneous Less common Malignant risk <5% ~20% (if with atypia) Management Microdochectomy Excision biopsy Upgrade rate Low Higher if atypia present Associated lesions Usually isolated ADH, LCIS possible BI-RADS 3-4 3-4 Recurrence Rare after excision Possible if multiple FIG 03 -- Differential diagnosis of nipple discharge Cause Features Management Intraductal papilloma Bloody, single duct, spontaneous Microdochectomy DCIS Bloody, multiple ducts Biopsy + surgery Breast cancer Bloody, mass present Triple assessment Duct ectasia Green / brown, bilateral, multiple Reassurance Galactorrhoea Milky, bilateral Prolactin, thyroid Hormonal (OCP / HRT) Milky, bilateral Medication review Fibrocystic change Serous, cyclical Reassurance Abscess / mastitis Purulent, systemic Antibiotics Normal (lactation) Milky, expected Reassurance FIG 04 -- Clinical pathway: intraductal papilloma 1 Spontaneous nipple discharge (bloody / serous) 2 Clinical assessment (single duct? mass? bilateral?) 3 USS + mammogram / MRI 4 Core biopsy if USS lesion seen 5 Microdochectomy (single duct) or total duct 6 Histology (benign vs upgrade to malignancy) FIG 05 -- Related procedures and variants Central papilloma (single duct) Peripheral papilloma (multiple) Papilloma with ADH Papilloma with DCIS Microdochectomy (Hadfield's op) Total duct excision (multiple / bilateral) FIG 06 -- Key statistics ~10% of benign breast conditions [1] <5% central papilloma upgrade to cancer [2] ~20% upgrade if atypical peripheral papilloma [3] Recurrence rare after complete excision [4] References 1. Brookes MJ et al. Nipple discharge -- benign to malignant spectrum. Breast 2009 2. Renshaw AA et al. Papilloma upgrade rate. Am J Clin Pathol 2004 3. NICE NG101. Early breast cancer 2023 4. NHS BSP. Guidance on B3 lesions 2022 5. Lewis JT et al. Peripheral papilloma risk. Am J Surg Pathol 2006 Clinically authored by Dr Fiona Tsang-Wright , FRCS (Gen Surg) GMC 4549831 · ORCID 0000-0003-4801-026X
Visual Reference · Intraductal papilloma
Open full size ↗
Definition
An intraductal papilloma is a small, benign, wart-like growth that develops inside one of the milk ducts of the breast and is the most common cause of clear or blood-stained discharge from a single duct of the nipple.

Common questions The questions patients ask first

Is an intraductal papilloma cancer?
No. An intraductal papilloma is benign by definition. A small minority show atypical features on examination of the whole specimen, and very occasionally a papilloma is associated with DCIS in the same area — which is one reason surgical removal is usually recommended even after a benign needle biopsy result.
Will the discharge stop on its own?
Sometimes the discharge from a small papilloma settles spontaneously, but it often persists or recurs. Surgical removal usually stops it reliably. There is no clinical pressure to remove an asymptomatic, biopsy-confirmed papilloma immediately, but ongoing discharge is the usual reason patients choose to proceed.
Can I still breastfeed if I have a papilloma?
Usually yes. Removing a single duct (microdochectomy) leaves the other ducts intact, and most patients who have breastfed after the operation report normal milk supply from the operated breast. Multiple-duct surgery affects breastfeeding more significantly and would be discussed at consultation if relevant.
Will the papilloma come back after surgery?
A completely removed papilloma does not recur in the same place. Some patients develop a new papilloma in a different duct in the months or years afterwards; this is uncommon and is investigated and managed in the same way.

An intraductal papilloma is a small, benign, wart-like growth that develops inside one of the milk ducts (on core biopsy it is often classified as B3 — a lesion of uncertain malignant potential; see the core biopsy glossary entry) of the breast and is the most common cause of clear or blood-stained discharge from a single duct of the nipple.

Most papillomas are benign and small. They usually present as single-duct nipple discharge, often noticed only as a stain on the inside of a bra. Solitary papillomas without atypia are usually removed — often by vacuum-assisted excision (VAE) under image guidance, sometimes by a small operation called microdochectomy — to confirm the diagnosis and stop discharge.

Orientation Why you might be reading about this

You have probably been told you have an intraductal papilloma, or you are reading about possible causes of nipple discharge. Single-duct discharge can be alarming when first noticed, and the word “papilloma” sounds more concerning than it usually is. This page explains what a papilloma is, why it is sometimes recommended for removal, and what that involves.

Related terms: Breast lump · Core biopsy · Breast ultrasound · DCIS · Microdochectomy

Definition What an intraductal papilloma is

A papilloma is a small finger-like or wart-like growth that develops inside one of the milk ducts behind the nipple. It is made of normal duct lining tissue arranged on a fibrovascular stalk1. Papillomas are usually small (a few millimetres to a centimetre), benign, and most often solitary — although a less common pattern, multiple peripheral papillomas, presents differently and is managed differently14.

The reason papillomas matter clinically is that they sit inside a duct and can cause bleeding or clear leakage from that single duct, which presents as nipple discharge. Because the discharge is from one specific duct (rather than the whole nipple), patients often notice it as a single recurring spot of fluid in the same place on the nipple, or a stain on the inside of one cup of a bra.

A small minority of papillomas have atypical features when examined by a pathologist — these are called papillomas with atypia are usually recommended for surgical excision and ongoing follow-up, rather than surveillance alone. Papillomas with atypia, are still benign, but carry a slightly raised future breast cancer risk and are usually recommended for surgical excision and ongoing follow-up.

Diagnosis How a papilloma is diagnosed

The standard pathway:

  • Clinical examination of the nipple, sometimes with gentle expression to confirm which duct the discharge is coming from.
  • Breast ultrasound — papillomas often appear as a small, well-defined nodule within a dilated duct, sometimes visible only when the duct contains discharge.
  • Mammogram — usually performed in older patients or where the imaging picture is unclear.
  • MRI — used in cases where ultrasound and mammogram do not resolve the picture, or where the discharge is bloody and persistent.
  • Core biopsy — taken from any visible lesion. Biopsy of a papilloma confirms the diagnosis but, importantly, may not capture every part of the lesion; this is one reason surgical removal is usually recommended after a biopsy diagnosis.

For a B3 papilloma without atypia on core biopsy, current UK NHSBSP/ABS guidance recommends vacuum-assisted excision (VAE) under image guidance as first-line management. Open surgical excision — usually a microdochectomy (removal of a single duct) or total duct excision (removal of all ducts) — is offered when there is atypia on biopsy, residual disease after VAE, persistent troublesome discharge, or patient preference.

When removal is recommended, the reasons usually include:

  • The needle biopsy samples only a small part of the lesion. Examining the whole specimen sometimes reveals atypical features or, occasionally, an associated DCIS that the needle biopsy did not capture2. Reported upgrade rates of biopsy-proven papilloma on excision vary across published series.
  • The discharge usually does not stop without removal, and recurrent or bloody discharge is socially troublesome.
  • A small papilloma is a small operation — usually a microdochectomy — with a quick recovery and a high likelihood of stopping the symptom3.

For papillomas where surveillance rather than removal is being considered, the decision is individual and is reviewed at the multidisciplinary team meeting.

Number matters Solitary versus multiple papillomas

  • Solitary papilloma — a single lesion, usually behind the nipple, typically presenting with single-duct discharge. The standard pattern this page describes1.
  • Multiple peripheral papillomas — a less common condition with several papillomas in the smaller ducts further out in the breast. These have a slightly higher associated risk of atypia or future cancer4 and are often managed with more extensive surgery and ongoing follow-up.

The two patterns look different on imaging and are managed differently; the surgical conversation is tailored to which pattern is present.

At consultation What to discuss with your surgeon

If you have been diagnosed with an intraductal papilloma, the conversation usually covers:

  • Whether removal is being recommended, and why.
  • The specific operation — for a solitary papilloma, this is usually a microdochectomy (single duct) or total duct excision when multiple ducts are involved.
  • What the histology report from the biopsy already shows, and what additional information the excised specimen will give.
  • Implications for future breastfeeding, sensation, and the cosmetic result.

Papillomas often present with nipple discharge, which is investigated in the same clinic visit.

Resources Further reading

Sources & guidance

Every figure on this page is anchored to a published source. Tap a number in the text or below to jump to the reference.

  1. reference text WHO Classification of Tumours Editorial Board. Breast Tumours. WHO Classification of Tumours, 5th edition, vol. 2. Lyon: International Agency for Research on Cancer. 2019 ;Papillary lesions of the breast https://tumourclassification.iarc.who.int/ Cited for: Definitions of intraductal papilloma (solitary, multiple, with/without atypia); benign classification with subtypes.
  2. meta analysis Wen X, Cheng W. Nonmalignant breast papillary lesions at core-needle biopsy: a meta-analysis of underestimation and influencing factors. Annals of Surgical Oncology. 2013 ;20(1):94–101 doi:10.1245/s10434-012-2590-1 Cited for: Upgrade rate of biopsy-proven papilloma to DCIS or invasive cancer on excision (literature range broadly 5–25% across heterogeneous series); rationale for surgical excision after needle biopsy.
  3. guidance Royal College of Surgeons / Association of Breast Surgery. Best Practice Diagnostic Guidelines for Patients Presenting with Breast Symptoms. London: ABS. 2010 ;Section: nipple discharge https://associationofbreastsurgery.org.uk/professionals/information-hub/guidelines/2010/best-practice-diagnostic-guidelines-for-patients-presenting-with-breast-cancer-symptoms Cited for: UK pathway for single-duct nipple discharge: examination, imaging, biopsy of any visible lesion; microdochectomy as standard surgical option.
  4. cohort Lewis JT, Hartmann LC, Vierkant RA, et al. An analysis of breast cancer risk in women with single, multiple, and atypical papilloma. American Journal of Surgical Pathology. 2006 ;30(6):665–672 doi:10.1097/00000478-200606000-00001 Cited for: Future breast cancer risk by papilloma subtype: solitary papilloma without atypia close to baseline; multiple papillomas and papillomas with atypia at higher risk.